Clinical Trial: Use of Propranolol Hydrochloride in the Treatment of Metastatic STS
Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional
Official Title: The Use of Propranolol Hydrochloride Combined With Anthracyclin Based Chemotherapy in the Treatment of Metastatic Soft Tissue Sarcoma
Brief Summary:
Fifty patients with pathological proof of malignant soft tissue sarcoma will receive Anthracyclin based chemotherapy combined with propranolol 40 mg twice daily.
- The primary end point : To assess Progression Free Survival (PFS)
- The secondary end points : To assess Overall Survival (OS) and Toxicity Profile
Detailed Summary:
Sponsor: Ain Shams University
Current Primary Outcome: Progression Free Survival [ Time Frame: an average of 1 year ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Overall Survival [ Time Frame: an average of 3 years ]
Original Secondary Outcome: Same as current
Information By: Ain Shams University
Dates:
Date Received: March 16, 2017
Date Started: August 30, 2017
Date Completion: August 30, 2019
Last Updated: April 5, 2017
Last Verified: April 2017